Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EMI Pharm is a Ukrainian pharmaceutical company dedicated to the development, registration, and marketing of generic medicines and dietary supplements. Headquartered in Kyiv, the company maintains a diverse portfolio targeting therapeutic areas such as gastroenterology, cardiology, and neurology. EMI Pharm collaborates with high-standard manufacturing partners to deliver affordable and effective treatments to the Ukrainian market. Their product line includes established brands like Enzytal and Gastro-norm, which address common gastrointestinal disorders. By focusing on market-driven needs and quality assurance, EMI Pharm has established itself as a reliable provider of essential healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EMI Pharm.